Bank of America’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,500,000
Closed -$7.61M 8011
2025
Q3
$7.61M Hold
1,500,000
﹤0.01% 3588
2025
Q2
$6.46M Buy
1,500,000
+500,000
+50% +$2.47M ﹤0.01% 3639
2025
Q1
$6.03M Buy
1,000,000
+608,200
+155% +$3.08M ﹤0.01% 3630
2024
Q4
$1.55M Hold
391,800
﹤0.01% 4661
2024
Q3
$2.29M Buy
391,800
+370,000
+1,697% +$1.82M ﹤0.01% 4457
2024
Q2
$94K Sell
21,800
-340,300
-94% -$1.63M ﹤0.01% 6273
2024
Q1
$1.7M Sell
362,100
-101,600
-22% -$389K ﹤0.01% 4549
2023
Q4
$2.28M Sell
463,700
-1,331,700
-74% -$6.52M ﹤0.01% 4280
2023
Q3
$9.78M Buy
1,795,400
+267,000
+17% +$2.14M ﹤0.01% 2736
2023
Q2
$14.2M Sell
1,528,400
-151,800
-9% -$1.28M ﹤0.01% 2354
2023
Q1
$13.8M Buy
1,680,200
+977,300
+139% +$10.8M ﹤0.01% 2506
2022
Q4
$7.83M Buy
+702,900
New +$8.17M ﹤0.01% 2921

Other funds holding MPT

Bank of America's MPT Position: Q1 2026 in Review

Bank of America reduced its Medical Properties Trust (MPT) stake by 7% in Q1 2026, selling an estimated $567K and leaving 1,433,014 shares worth $6.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3253.

Bank of America first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $101M in Q2 2019. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Bank of America held 1,433,014 shares of Medical Properties Trust worth $6.63M as of Q1 2026.
  • Bank of America sold 108,688 Medical Properties Trust shares in Q1 2026, an estimated $567K.
  • Medical Properties Trust made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3253 holding.
  • Bank of America first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Medical Properties Trust position peaked at $101M in Q2 2019.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.